RDH12退:

Tomas S Aleman1,2, Alejandro J Roman1, Katherine E Uyhazi1

  • 1Scheie Eye Institute, Department of Ophthalmology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States.

概括

这项研究追踪了RDH12相关的Leber先天性黄斑症 (RDH12-LCA) 的儿科患者的光受体疾病. 治疗应针对状,以减缓进展,以及周状棒,以改善夜视.